~~<i id='1A2D5564E1'><strike id='1A2D5564E1'><tt id='1A2D5564E1'><pre id='1A2D5564E1'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

leisure time

author：Wikipedia 2025-09-06 03:17:36 - browse：11

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Why you get paid to donate plasma but not blood

hotspot

Wikipedia

hotspot

explore

leisure time

AdobeWhenshestoppedgettingherperiodinMarch2022,DarynSchwartzwasn’tespeciallyconcerned.At42,shehadrec

WSS

How climate

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Johnson & Johnson sues to stop Medicare negotiation

FDA warns J&J's Abiomed: We will regulate your software

STAT Summit: GSK CEO on pharma giant's new direction

A Theranos scientist

entertainment

leisure time

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

FDA warns J&J's Abiomed: We will regulate your software

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Dobbs anniversary: the lost opportunity of abortion as health care

ER docs worry over extreme heat as a 'mass casualty event'

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Study: Hearing aids may slow cognitive decline in those at risk

Affirmative action in medical school literally saved lives

FDA gives detailed accounting of AI

Wikipedia

Hospital price transparency does save money, advocate argues

First Opinion Podcast: Long Covid needs a new approach

STAT Summit: Michael J. Fox on progress in Parkinson's research

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

How climate

The EU Joint Clinical Assessment needs to live up to its promise

hotspot

explore

leisure time

leisure time